Details for New Drug Application (NDA): 202539
NDA 202539 describes PARICALCITOL, which is a drug marketed by Amneal Pharms, Aurobindo Pharma Ltd, Bionpharma, Chartwell Rx, Lotus Pharm Co Ltd, Pharmazone, Rising, Teva Pharms Usa, Accord Hlthcare, Amneal Pharms Co, Caplin, Epic Pharma Llc, Eugia Pharma, Hikma Pharms, Hospira, and Sandoz, and is included in seventeen NDAs. It is available from ten suppliers. Additional details are available on the PARICALCITOL profile page.
The generic ingredient in PARICALCITOL is paricalcitol. There is one drug master file entry for this compound. Eleven suppliers are listed for this compound. Additional details are available on the paricalcitol profile page.
The generic ingredient in PARICALCITOL is paricalcitol. There is one drug master file entry for this compound. Eleven suppliers are listed for this compound. Additional details are available on the paricalcitol profile page.
Summary for 202539
| Tradename: | PARICALCITOL |
| Applicant: | Bionpharma |
| Ingredient: | paricalcitol |
| Patents: | 0 |
Suppliers and Packaging for NDA: 202539
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PARICALCITOL | paricalcitol | CAPSULE;ORAL | 202539 | ANDA | Bryant Ranch Prepack | 63629-2452 | 63629-2452-1 | 30 CAPSULE in 1 BOTTLE, PLASTIC (63629-2452-1) |
| PARICALCITOL | paricalcitol | CAPSULE;ORAL | 202539 | ANDA | Bryant Ranch Prepack | 63629-2453 | 63629-2453-1 | 30 CAPSULE in 1 BOTTLE, PLASTIC (63629-2453-1) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 1MCG | ||||
| Approval Date: | Mar 27, 2014 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 2MCG | ||||
| Approval Date: | Mar 27, 2014 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 4MCG | ||||
| Approval Date: | Mar 27, 2014 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
